back
Share
Senate Interim Study
Evaluating the Feasibility of Omnipod Coverage for Medicaid
Date
Time 9:00am
Location ,
Senate Room 230, State Capitol Building
Description: To evaluate the feasibility and potential benefits of including Omnipod coverage under Medicaid. This study will examine the clinical effectiveness, cost implications, and accessibility of Omnipod insulin management systems for Medicaid beneficiaries. Additionally, it will assess the impact of Omnipod coverage on patient outcomes, quality of life, and overall healthcare costs. The goal is to provide data-driven insights and policy recommendations to inform the potential integration of Omnipod devices into Medicaid coverage plans.
- Senator Carri Hicks; Opening Remarks
- Amber Clour; Lives with Type 1 & Founder of Diabetes Daily Grind Podcast
- Christina Foss; Oklahoma Health Care Authority, Chief of Staff
- Ryan Bucalo; Insulet, Director of National Accounts - Medicaid Markets
- Trish Winters; Breakthrough T1D, Market Director